T-cell recognition of HLA-DQ2-bound gluten peptides can be influenced by an N-terminal proline at p-1
- 16 February 2005
- journal article
- research article
- Published by Springer Nature in Immunogenetics
- Vol. 57 (1-2) , 8-15
- https://doi.org/10.1007/s00251-005-0780-8
Abstract
Recent research has implicated a large number of gluten-derived peptides in the pathogenesis of celiac disease, a preponderantly HLA-DQ2-associated disorder. Current evidence indicates that the core of some of those peptides is ten amino acids long, while HLA class II normally accommodates nine amino acids in the binding groove. We have now investigated this in detail, using gluten-specific T-cell clones, HLA-DQ2-specific peptide-binding assays and molecular modelling. T-cell recognition of both a γ-gliadin peptide and a low-molecular-weight glutenin peptide was found to be strictly dependent on a ten-amino acids-long peptide. Subsequent peptide-binding studies indicated that the glutenin peptide bound in a conventional p1/p9 register, with an additional proline at p-1. Testing of substitution analogues demonstrated that the nature of the amino acid at p-1 strongly influenced T-cell recognition of the peptide. Moreover, molecular modelling confirmed that the glutenin peptide binds in a p1/p9 register, and that the proline at p-1 points upward towards the T-cell receptor. Database searches indicate that a large number of potential T-cell stimulatory gluten peptides with an additional proline at relative position p-1 exist, suggesting that the recognition of other gluten peptides may depend on this proline as well. This knowledge may be of importance for the identification of additional T-cell stimulatory gluten peptides and the design of a peptide-based, tolerance-inducing therapy.Keywords
This publication has 26 references indexed in Scilit:
- Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac diseaseProceedings of the National Academy of Sciences, 2004
- Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac DiseaseThe Journal of Experimental Medicine, 2002
- Structure of a Complex of the Human α/β T Cell Receptor (TCR) HA1.7, Influenza Hemagglutinin Peptide, and Major Histocompatibility Complex Class II Molecule, HLA-DR4 (DRA0101 and DRB10401)The Journal of Experimental Medicine, 2002
- Unique peptide binding characteristics of the disease-associated DQ(α1 * 0501, β1 * 0201) vs the non-disease-associated DQ(α1 * 0201, β1 * 0202) moleculeImmunogenetics, 1997
- Preferential presentation of herpes simplex virus T-cell antigen by HLA DQA1*0501/DQB1*0201 in comparison to HLA DQA1*0201/DQB1*0201Human Immunology, 1997
- The peptide binding motif of the disease associated HLA‐DQ (α 1* 0501, β 1* 0201) moleculeEuropean Journal of Immunology, 1996
- Peptide binding characteristics of the coeliac disease-associated DQ(α1*0501, β1*0201) moleculeImmunogenetics, 1996
- Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides.Proceedings of the National Academy of Sciences, 1996
- Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer.The Journal of Experimental Medicine, 1989
- Vergleichende Untersuchungen über partielle Aminosäuresequenzen von Prolaminen und Glutelinen verschiedener GetreideartenZeitschrift für Lebensmittel-Untersuchung und Forschung, 1980